South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

covidien (pty) ltd - injection - each 100 ml contains sodium iothalamate 54 g

United States - English - NLM (National Library of Medicine)

liebel-flarsheim company llc - iothalamate meglumine (unii: xuw72gop7w) (iothalamic acid - unii:16chd79mix) - iothalamate meglumine 600 mg in 1 ml - conray is indicated for use in excretory urography, cerebral angiography, peripheral arteriography, venography, arthrography, direct cholangiography, endoscopic retrograde cholangiopancreatography, contrast enhancement of computed tomographic brain images, cranial computerized angiotomography, intravenous digital subtraction angiography and arterial digital subtraction angiography. conray may also be used for enhancement of computed tomographic scans performed for detection and evaluation of lesions in the liver, pancreas, kidneys, abdominal aorta, mediastinum, abdominal cavity and retroperitoneal space. continuous or multiple scans separated by intervals of 1 to 3 seconds during the first 30 to 90 seconds post-injection of the contrast medium (dynamic ct scanning) may provide enhancement of diagnostic significance, and may be of benefit in establishing diagnoses of certain lesions in these sites with greater assurance than is possible with ct alone, and in supplying additional features of the lesions. in oth

United States - English - NLM (National Library of Medicine)

liebel-flarsheim company llc - iothalamate meglumine (unii: xuw72gop7w) (iothalamic acid - unii:16chd79mix) - iothalamate meglumine 430 mg in 1 ml - conray 43 is indicated for use in lower extremity venography, intravenous infusion urography, contrast enhancement of computed tomographic brain images and arterial digital subtraction angiography. conray 43 may also be used for enhancement of computed tomographic scans performed for detection and evaluation of lesions in the liver, pancreas, kidneys, abdominal aorta, mediastinum, abdominal cavity and retroperitoneal space. continuous or multiple scans separated by intervals of 1 to 3 seconds during the first 30 to 90 seconds post-injection of the contrast medium (dynamic ct scanning) may provide enhancement of diagnostic significance, and may be of benefit in establishing diagnoses of certain lesions in these sites with greater assurance than is possible with ct alone and in supplying additional features of the lesions. in other cases, the contrast agent may allow visualization of lesions not seen with ct alone, or may help to define suspicious lesions seen with unenhanced ct (see clinical pharmacology). su

Ireland - English - HPRA (Health Products Regulatory Authority)

covidien (uk) commerical limited - iotalamate meglumine - solution for injection - 14/50

Australia - English - Department of Health (Therapeutic Goods Administration)

mallinckrodt australia pty ltd - meglumine iothalamate -

Ireland - English - HPRA (Health Products Regulatory Authority)

mallinckrodt uk commercial ltd - iotalamate meglumine - solution for injection - 14/50 micromol

United States - English - NLM (National Library of Medicine)

liebel-flarsheim company llc - iothalamate meglumine (unii: xuw72gop7w) (iothalamic acid - unii:16chd79mix) - iothalamate meglumine 172 mg in 1 ml - cysto-conray ii is indicated for use in retrograde cystography and cystourethrography. see warnings concerning inadvertant intrathecal administration.

United States - English - NLM (National Library of Medicine)

liebel-flarsheim company llc - iothalamate meglumine (unii: xuw72gop7w) (iothalamic acid - unii:16chd79mix) - iothalamate meglumine 300 mg in 1 ml

Canada - English - Health Canada

liebel-flarsheim company llc - iothalamate meglumine - solution - 172mg - iothalamate meglumine 172mg - roentgenography

New Zealand - English - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - meglumine iotalamate 52%; sodium iotalamate 26% - solution for injection - 52%/26% - active: meglumine iotalamate 52% sodium iotalamate 26%